AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15224278 — intervention group
Group type: EXPERIMENTAL
Intervention: Retreatment
Number of subjects: 573
Study 12044534 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha‐2b (6 MU three times per week for 24 weeks followed by 3 MU three times per week for 24 weeks) alone (group A)
Number of subjects: 376
Study 12044534 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b (6 MU three times per week for 24 weeks followed by 3 MU three times per week for 24 weeks) in combination with ribavirin for 48 weeks (group B)
Number of subjects: 376
Study 12044534 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily interferon alpha‐2b (3 MU per day for 24 weeks followed by 3 MU three times per week for 24 weeks) and ribavirin (group C)
Number of subjects: 376
Study 12044534 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with three times weekly interferon and ribavirin
Number of subjects: 376
Study 12044534 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily interferon and ribavirin
Number of subjects: 376
Study 12044534 — intervention group
Group type: COMPARATOR
Intervention: Interferon alone
Number of subjects: 376
Study 9666365 — intervention group
Group type: EXPERIMENTAL
Intervention: Playground based instruction on bicycle handling skills by certified instructors
Number of subjects: 141
Study 8123947 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin 500 units and Hydrocortisone 10 mg/L
Number of subjects: 0
Study 8123947 — intervention group
Group type: COMPARATOR
Intervention: In-line filter with drug-free infusate
Number of subjects: 0
Study 8123947 — intervention group
Group type: EXPERIMENTAL
Intervention: Long intravenous catheters (30 cm)
Number of subjects: 0
Study 8123947 — intervention group
Group type: COMPARATOR
Intervention: Short intravenous catheters
Number of subjects: 0
Study 2700316 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole liver radiation therapy (RT) alone
Number of subjects: 0
Study 2700316 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole liver radiation therapy (RT) combined with chemotherapy (systemic and/or intra-hepatic)
Number of subjects: 0
Study 2700316 — intervention group
Group type: EXPERIMENTAL
Intervention: Misonidazole
Number of subjects: 0
Study 2700316 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative techniques of delivering RT (intraoperative brachytherapy, radiolabeled antibodies, hyperfractionated external beam RT)
Number of subjects: 0
Study 782261 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 81
Study 782261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 30452919 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 122
Study 30452919 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 122
Study 28262676 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention (3 sessions/week of moderate intensity aerobic and resistance training for 12 weeks)
Number of subjects: 24
Study 28262676 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention
Number of subjects: 24
Study 28262676 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 24
Study 25386736 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF/FTC/EFZ
Number of subjects: 14
Study 25386736 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF/FTC plus LPV/r
Number of subjects: 14
Study 25386736 — intervention group
Group type: COMPARATOR
Intervention: TDF/FTC/EFZ or TDF/FTC plus LPV/r
Number of subjects: 14
Study 23114890 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) under general anaesthetic (GA)
Number of subjects: 23
Study 23114890 — intervention group
Group type: COMPARATOR
Intervention: Single incision sling (SIS) under local anaesthetic (LA)
Number of subjects: 23
Study 21142948 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal A (60g pasta, 150g grilled courgettes, 25g uncooked oil)
Number of subjects: 12
Study 21142948 — intervention group
Group type: COMPARATOR
Intervention: Meal B (15g oil in 150g deep-fried courgettes, 10g oil in 60g stir-fried pasta)
Number of subjects: 12
Study 20633498 — intervention group
Group type: EXPERIMENTAL
Intervention: Distilled Rehmannia glutinosa pharmacopuncture
Number of subjects: 120
Study 20633498 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild Ginseng pharmacopuncture
Number of subjects: 120
Study 20633498 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragali Radix pharmacopuncture
Number of subjects: 120
Study 20633498 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injection (Control)
Number of subjects: 120
Study 17371783 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg daily)
Number of subjects: 49
Study 17371783 — intervention group
Group type: COMPARATOR
Intervention: No-beta-blockade
Number of subjects: 49
Study 15726550 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol up to 3 g/d
Number of subjects: 8633
Study 15726550 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin up to 3 g/d
Number of subjects: 8633
Study 15726550 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen up to 1200 mg/d
Number of subjects: 8633
Study 12238905 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (Bricanyl, 5.0 mg/2ml)
Number of subjects: 108
Study 12238905 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (Berotec, 1.25 mg/2ml)
Number of subjects: 108
Study 9620106 — intervention group
Group type: EXPERIMENTAL
Intervention: Antifungal prophylaxis (systemic, intranasal, lipid formulations of amphotericin B, fluconazole, itraconazole)
Number of subjects: 0
Study 9620106 — intervention group
Group type: EXPERIMENTAL
Intervention: Antifungal prophylaxis
Number of subjects: 0
Study 7865418 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton rolls isolation and cleaning of occlusal surface using a bristle brush and non-fluoridated paste
Number of subjects: 95
Study 7865418 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber dam isolation and mechanical preparation of pits and fissures using a round bur No. 0 in a slow hand‐piece
Number of subjects: 95
Study 7865418 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber dam isolation and cleaning of occlusal surface using a bristle brush and non-fluoridated paste
Number of subjects: 95
Study 7865418 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton rolls isolation and mechanical preparation of pits and fissures using a round bur No. 0 in a slow hand‐piece
Number of subjects: 95
Study 2606162 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal education programme on toxoplasmosis
Number of subjects: 52
Study 2606162 — intervention group
Group type: COMPARATOR
Intervention: Routine class material (control)
Number of subjects: 52
Study 31289040 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab and ipilimumab (perioperative immunotherapy)
Number of subjects: 0
Study 28682837 — intervention group
Group type: COMPARATOR
Intervention: Formula-based bolus resuscitation
Number of subjects: 7
Study 28682837 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiautonomous (decision assist) fluid administration
Number of subjects: 7
Study 28682837 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully autonomous (closed loop) resuscitation
Number of subjects: 7
Study 25504576 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (ET) for 8 weeks
Number of subjects: 0
Study 22848080 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic exercise
Number of subjects: 21
Study 22848080 — intervention group
Group type: COMPARATOR
Intervention: Blockade day (combined oral H(1) and H(2) receptor antagonism with fexofenadine and ranitidine)
Number of subjects: 21
Study 22848080 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 21
Study 21812847 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal counselling (1-6 sessions, mean 4.6)
Number of subjects: 103
Study 21812847 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 103
Study 21812847 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal counselling (for patients under 60 years)
Number of subjects: 103
Study 19226297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl (Group Ft)
Number of subjects: 120
Study 19226297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (Group Fv)
Number of subjects: 120
Study 19226297 — intervention group
Group type: COMPARATOR
Intervention: Isobaric bupivacaine alone (Group B)
Number of subjects: 120
Study 12486749 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective exclusion of treatment arms in multi-arm randomized clinical trials
Number of subjects: 0
Study 9987698 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 32
Study 9987698 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 400 mg
Number of subjects: 32
Study 9987698 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 600 mg
Number of subjects: 32
Study 9987698 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 800 mg
Number of subjects: 32
Study 9987698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 8749241 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg orally
Number of subjects: 0
Study 8749241 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg as suppository or 10‐20 mg orally
Number of subjects: 0
Study 8749241 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg acetylsalicylic acid as effervescent tablets
Number of subjects: 0
Study 8749241 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg paracetamol as effervescent tablets or suppositories
Number of subjects: 0
Study 8749241 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 500-1,000 mg
Number of subjects: 0
Study 8749241 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400-800 mg
Number of subjects: 0
Study 8749241 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs (diclofenac, mefenamic acid, ketoprofen, tolfenamic acid, pirprofen)
Number of subjects: 0
Study 8749241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8749241 — intervention group
Group type: COMPARATOR
Intervention: Standard reference drugs
Number of subjects: 0
Study 2080867 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal interferon alpha-2a
Number of subjects: 0
Study 2080867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7351286 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg prostaglandin E2 three times daily
Number of subjects: 18
Study 7351286 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 18
Study 31811429 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) for patients with nodal grouping (NG) in stages N1 and N2
Number of subjects: 1224
Study 31152080 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (75 mg/m2 intravenously every 3 weeks) plus Prednisone (5 mg twice daily) plus Cediranib (30 mg once daily)
Number of subjects: 58
Study 31152080 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 intravenously every 3 weeks) plus Prednisone (5 mg twice daily)
Number of subjects: 58
Study 28591543 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich beverage during a 3-week training phase before marathon
Number of subjects: 100
Study 28591543 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 100
Study 26337720 — intervention group
Group type: EXPERIMENTAL
Intervention: Walker boot
Number of subjects: 18
Study 26337720 — intervention group
Group type: COMPARATOR
Intervention: Tubigrip
Number of subjects: 18
Study 26337720 — intervention group
Group type: COMPARATOR
Intervention: Stirrup brace
Number of subjects: 18
Study 23673347 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR (50-300 mg/d)
Number of subjects: 1808
Study 23673347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1808
Study 21359690 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivor Health and Resilience Education (SHARE) Program intervention
Number of subjects: 75
Study 21359690 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 75
Study 19624286 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation containing PLC, L‐Arg and nicotinic acid (Ezerex)
Number of subjects: 40
Study 19624286 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil (Levitra) 20 mg twice a week
Number of subjects: 40
Study 19624286 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation plus vardenafil 20 mg twice a week
Number of subjects: 40
Study 19624286 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules twice weekly
Number of subjects: 40
Study 17583820 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbscan pachymetry measurements
Number of subjects: 40
Study 17583820 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic pachymetry measurements
Number of subjects: 40
Study 17583820 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between Orbscan and ultrasonic pachymetry
Number of subjects: 40
Study 17583820 — intervention group
Group type: EXPERIMENTAL
Intervention: Pachymetry measurements grouped by diagnoses
Number of subjects: 40
Study 15291499 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mL of fresh Sweetie juice
Number of subjects: 72
Study 15291499 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mL of fresh Sweetie juice
Number of subjects: 72
Study 15291499 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 72
Study 11414349 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 122
Study 11414349 — intervention group
Group type: COMPARATOR
Intervention: Nondirective Reflective Listening (NDRL)
Number of subjects: 122
Study 11414349 — intervention group
Group type: COMPARATOR
Intervention: No Further Counseling (NFC)
Number of subjects: 122
Study 9459232 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg after surgery (Group D)
Number of subjects: 164
Study 9459232 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg before induction (Group C)
Number of subjects: 164
Study 9459232 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 2 mg at the start of and 2 mg after surgery (Group B)
Number of subjects: 164
Study 9459232 — intervention group
Group type: COMPARATOR
Intervention: placebo (Group A)
Number of subjects: 164
Study 7918285 — intervention group
Group type: EXPERIMENTAL
Intervention: Peribulbar and retrobulbar anaesthesia
Number of subjects: 104
Study 7918285 — intervention group
Group type: COMPARATOR
Intervention: No external ocular compression
Number of subjects: 104
Study 7918285 — intervention group
Group type: COMPARATOR
Intervention: External ocular compression
Number of subjects: 104
Study 7918285 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with glaucoma
Number of subjects: 104
Study 28805107 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 24
Study 28805107 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study 26137850 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal compound containing Malva sylvestris and Alcea digitata (Boiss)
Number of subjects: 62
Study 26137850 — intervention group
Group type: COMPARATOR
Intervention: Artificial saliva (Hypozalix)
Number of subjects: 62
Study 25343373 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT group (curcumin and blue light)
Number of subjects: 27
Study 25343373 — intervention group
Group type: COMPARATOR
Intervention: Light group (blue light only)
Number of subjects: 27
Study 25343373 — intervention group
Group type: COMPARATOR
Intervention: Curcumin group (curcumin only)
Number of subjects: 27
Study 22971901 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally targeted video
Number of subjects: 664
Study 22971901 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic video
Number of subjects: 664
Study 22971901 — intervention group
Group type: COMPARATOR
Intervention: Fact sheet (control)
Number of subjects: 664
Study 22971901 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally targeted video (subgroup analysis)
Number of subjects: 664
Study 22971901 — intervention group
Group type: EXPERIMENTAL
Intervention: Both video groups
Number of subjects: 664
Study 20435864 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exacerbation pulmonary rehabilitation (PEPR)
Number of subjects: 60
Study 20435864 — intervention group
Group type: COMPARATOR
Intervention: Usual follow-up care (UC)
Number of subjects: 60
Study 19011260 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Monitoring (HM) technology
Number of subjects: 166
Study 16892907 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccine
Number of subjects: 0
Study 16892907 — intervention group
Group type: COMPARATOR
Intervention: Community-level covariates (study arm and immunization levels)
Number of subjects: 0
Study 15277374 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-fat/moderate-carbohydrate diet
Number of subjects: 40
Study 15277374 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat/high-carbohydrate diet
Number of subjects: 40
Study 11404758 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonding alloy with chamfer finish line (group BA)
Number of subjects: 4
Study 11404758 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold alloy with chamfer finish line (group G)
Number of subjects: 4
Study 11404758 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcelain with chamfer finish line (group PC)
Number of subjects: 4
Study 11404758 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcelain with shoulder finish line (group PS)
Number of subjects: 4
Study 11404758 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical LE distances for all groups
Number of subjects: 4
Study 9423503 — intervention group
Group type: EXPERIMENTAL
Intervention: In‐House Counselling (IHC) group
Number of subjects: 188
Study 9423503 — intervention group
Group type: COMPARATOR
Intervention: Routine Treatment (RT) group
Number of subjects: 188
Study 8215672 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 60
Study 8215672 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugation
Number of subjects: 60
Study 8215672 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct infusion
Number of subjects: 60
Study 3115130 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) nasal spray
Number of subjects: 77
Study 3115130 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyposensitization with aluminium hydroxide adsorbed extract of grass pollen
Number of subjects: 77
Study 3115130 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sodium cromoglycate and hyposensitization
Number of subjects: 77
Study 3115130 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 77
Study 29897544 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-g LP bar (11 g protein with 2 g added LP)
Number of subjects: 40
Study 29897544 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-g LP bar (13 g protein with 3 g added LP)
Number of subjects: 40
Study 29897544 — intervention group
Group type: COMPARATOR
Intervention: 0-g LP bar (9 g protein with 0 g added LP)
Number of subjects: 40
Study 26971086 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical fixation technique
Number of subjects: 24
Study 26971086 — intervention group
Group type: COMPARATOR
Intervention: U-shaped ulnar gutter splinting
Number of subjects: 24
Study 24681342 — intervention group
Group type: EXPERIMENTAL
Intervention: Y90 + sorafenib (Group B)
Number of subjects: 20
Study 24681342 — intervention group
Group type: COMPARATOR
Intervention: Y90 alone (Group A)
Number of subjects: 20
Study 22493913 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint sticking therapy during dog days and the three nine‐day periods after the winter solstice (Group A)
Number of subjects: 150
Study 22493913 — intervention group
Group type: COMPARATOR
Intervention: Acupoint sticking therapy during dog days (Group B)
Number of subjects: 150
Study 22493913 — intervention group
Group type: COMPARATOR
Intervention: Acupoint sticking therapy during the three nine‐day periods after the winter solstice (Group C)
Number of subjects: 150
Study 22493913 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 150
Study 22493913 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A vs Group B and Group C
Number of subjects: 150
Study 22493913 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B vs Group C
Number of subjects: 150
Study 20074353 — intervention group
Group type: COMPARATOR
Intervention: Expert-led training
Number of subjects: 132
Study 20074353 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led training
Number of subjects: 132
Study 20074353 — intervention group
Group type: COMPARATOR
Intervention: Comparison of High Pass grades
Number of subjects: 132
Study 18199302 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol Use Disorders Identification Test (AUDIT) screening questionnaire
Number of subjects: 421
Study 18199302 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-screened)
Number of subjects: 421
Study 15890634 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DEX) 60 mg
Number of subjects: 0
Study 15890634 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DEX) 90 mg
Number of subjects: 0
Study 15890634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12753447 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1 micro g.kg‐1 i.v.
Number of subjects: 29
Study 12753447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 10593672 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 mg/kg daily for 10 days orally)
Number of subjects: 42
Study 10593672 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 42
Study 10593672 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42